Company Filing History:
Years Active: 2024
Title: Innovative Contributions of Dongjoon Ko
Introduction
Dongjoon Ko is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology through his innovative work, particularly in antibody development.
Latest Patents
Dongjoon Ko holds a patent for a TM4SF5-targeting humanized antibody and its applications. This patent relates to TM4SF5-specific humanized antibodies and explores their uses in various therapeutic contexts. This groundbreaking invention showcases Ko's expertise in antibody engineering and its potential impact on medical treatments.
Career Highlights
Throughout his career, Dongjoon Ko has been associated with prominent research institutions, including the Korea Research Institute of Bioscience and Biotechnology and the Seoul National University R&DB Foundation. His experience at these organizations has contributed to his professional growth and innovation in biotechnology.
Collaborations
Ko has collaborated with fellow researcher Se Mi Kim, highlighting the importance of teamwork in advancing scientific discoveries. Their partnership underscores the collaborative nature of research in the field of biotechnology.
Conclusion
Dongjoon Ko's innovative contributions, particularly in the development of humanized antibodies, position him as a key figure in advancing biotechnological research. His patent reflects his commitment to improving health outcomes through scientific innovation.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.